-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Initiates Coverage On Entera Bio with Outperform Rating, Announces Price Target of $9

Benzinga·09/18/2026 13:19:12
Listen to the news
Leerink Partners analyst David Risinger initiates coverage on Entera Bio (NASDAQ:ENTX) with a Outperform rating and announces Price Target of $9.